These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 25823248)

  • 1. [Contribution of central hospital laboratory to critical bleeding].
    Kawahara Y; Watanabe Y; Tomoda Y; Kino S
    Rinsho Byori; 2014 Dec; 62(12):1286-94. PubMed ID: 25823248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Team approaches to critical bleeding (massive bleeding and transfusion) - chairmen's introductory remarks. Questionnaire survey on current status of hospital clinical laboratories evaluating critical hemorrhage].
    Kino S; Suwabe A
    Rinsho Byori; 2014 Dec; 62(12):1268-74. PubMed ID: 25823245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Role of the clinical laboratory for patients with massive transfusion undergoing elective surgery].
    Kino S; Takenaka S; Niizeki N; Hanada D; Tomoda Y; Akasaka K; Ito Y
    Rinsho Byori; 2011 Jul; 59(7):670-5. PubMed ID: 21874793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased thrombin generation and fibrinogen level after therapeutic plasma transfusion: relation to bleeding.
    Schols SE; van der Meijden PE; van Oerle R; Curvers J; Heemskerk JW; van Pampus EC
    Thromb Haemost; 2008 Jan; 99(1):64-70. PubMed ID: 18217136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Required laboratory examination and blood transfusion therapy in massive hemorrhage during surgery].
    Yamamoto K
    Rinsho Byori; 2011 Jul; 59(7):678-83. PubMed ID: 21874794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma and plasma products in the treatment of massive haemorrhage.
    Erber WN; Perry DJ
    Best Pract Res Clin Haematol; 2006; 19(1):97-112. PubMed ID: 16377544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coagulation management in trauma-associated coagulopathy: allogenic blood products versus coagulation factor concentrates in trauma care.
    Klages M; Zacharowski K; Weber CF
    Curr Opin Anaesthesiol; 2016 Apr; 29(2):245-9. PubMed ID: 26784352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of massive operative blood loss.
    Kozek-Langenecker S
    Minerva Anestesiol; 2007; 73(7-8):401-15. PubMed ID: 17380100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exsanguination in trauma: A review of diagnostics and treatment options.
    Geeraedts LM; Kaasjager HA; van Vugt AB; Frölke JP
    Injury; 2009 Jan; 40(1):11-20. PubMed ID: 19135193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Patient blood management and transfusion therapy for hemostasis].
    Yamamoto K
    Rinsho Ketsueki; 2017; 58(10):2141-2149. PubMed ID: 28978859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Examination of the sample centrifugation time for emergency coagulation test].
    Watanabe Y; Kawahara Y; Hanada D; Nozawa K; Tomoda Y; Kino S
    Rinsho Byori; 2012 Nov; 60(11):1035-9. PubMed ID: 23383570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The early use of fibrinogen, prothrombin complex concentrate, and recombinant-activated factor VIIa in massive bleeding.
    Fries D
    Transfusion; 2013 Jan; 53 Suppl 1():91S-95S. PubMed ID: 23301979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-care versus central laboratory coagulation testing during haemorrhagic surgery. A multicenter study.
    Toulon P; Ozier Y; Ankri A; Fléron MH; Leroux G; Samama CM
    Thromb Haemost; 2009 Feb; 101(2):394-401. PubMed ID: 19190827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations.
    Fenger-Eriksen C; Lindberg-Larsen M; Christensen AQ; Ingerslev J; Sørensen B
    Br J Anaesth; 2008 Dec; 101(6):769-73. PubMed ID: 18818192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study.
    Görlinger K; Dirkmann D; Hanke AA; Kamler M; Kottenberg E; Thielmann M; Jakob H; Peters J
    Anesthesiology; 2011 Dec; 115(6):1179-91. PubMed ID: 21970887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Noncitrated whole blood is optimal for evaluation of postinjury coagulopathy with point-of-care rapid thrombelastography.
    Kashuk JL; Moore EE; Le T; Lawrence J; Pezold M; Johnson JL; Cothren CC; Biffl WL; Barnett C; Sabel A
    J Surg Res; 2009 Sep; 156(1):133-8. PubMed ID: 19577246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of hemorrhage in cardiothoracic surgery.
    Görlinger K; Shore-Lesserson L; Dirkmann D; Hanke AA; Rahe-Meyer N; Tanaka KA
    J Cardiothorac Vasc Anesth; 2013 Aug; 27(4 Suppl):S20-34. PubMed ID: 23910533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriateness of transfusions of red cells, platelets and fresh frozen plasma. An audit in a tertiary care teaching hospital.
    Metz J; McGrath KM; Copperchini ML; Haeusler M; Haysom HE; Gibson PR; Millar RJ; Babarczy A; Ferris L; Grigg AP
    Med J Aust; 1995 Jun; 162(11):572-3, 576-7. PubMed ID: 7791642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of cryoprecipitate in human and canine transfusion medicine.
    Prittie J
    J Vet Emerg Crit Care (San Antonio); 2021 Mar; 31(2):204-214. PubMed ID: 33751762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative dilutional coagulopathy treated with fresh frozen plasma and fibrinogen concentrate: a prospective randomized intervention trial.
    Lancé MD; Ninivaggi M; Schols SE; Feijge MA; Oehrl SK; Kuiper GJ; Nikiforou M; Marcus MA; Hamulyak K; van Pampus EC; ten Cate H; Heemskerk JW
    Vox Sang; 2012 Jul; 103(1):25-34. PubMed ID: 22211833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.